VPAS: Achievement so far on objectives for the economy and innovationIn the third part of this series taking stock of the 2019 Voluntary Scheme for Branded Medicines Pricing and Share XVPAS: Achievement so far on objectives for the economy and innovationhttps://pharmaphorum.com/views-analysis-market-access/vpas-achievement-so-far-on-objectives-for-the-economy-and-innovation/
VPAS: Achievements so far on affordabilityIn the second part of this series taking stock of the 2019 Voluntary Scheme for Branded Medicines Pricing Share XVPAS: Achievements so far on affordabilityhttps://pharmaphorum.com/views-analysis-market-access/vpas-achievements-so-far-on-affordability/
VPAS: Achievement so far on objectives for patientsThe UK has a voluntary agreement that was struck by the government and NHS England (now referred to Share XVPAS: Achievement so far on objectives for patientshttps://pharmaphorum.com/views-analysis-market-access/vpas-achievement-so-far-on-objectives-for-patients/
